Diverging humoral and cellular immune responses due to Omicron—a national study from the Faroe Islands
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltime
Final published version, 3.01 MB, PDF document
Immunity following infection and vaccination with the SARS-CoV-2 Omicron variant is poorly understood. The aim was to investigate immunity assessed with antibody response, neutralizing antibodies (NAbs), and IFN-γ release under different scenarios∶ in vaccinated and unvaccinated individuals with and without SARS-CoV-2 infection with the Omicron variant. This nationwide single-center study was conducted between January and March 2022, where all convalescent individuals were infected with the Omicron variant and included six study groups∶ unvaccinated-naïve, unvaccinated convalescent, vaccinated-naïve (second dose), vaccinated-naïve (third dose), vaccinated convalescent (second dose), and vaccinated convalescent (third dose). Antibody responses were assessed by determining receptor binding domain-specific antibodies and NAbs levels in serum, and IgG in saliva. T-cell responses in whole blood were measured as IFN-γ levels released after stimulation with spike peptides. We found that the humoral response against the spike protein was higher among vaccinated-naïve than unvaccinated convalescent. Unvaccinated with and without infection had comparable low humoral responses, while those vaccinated with a second or third dose, independent of infection status, had increasingly higher levels. Only 22% of the unvaccinated convalescent individuals mounted consistent detectable humoral responses following Omicron infection. However, 98% had spike peptide T-cell responses assessed by IFN-γ release. In conclusion, primary Omicron infection mounts a low humoral immune response, significantly enhanced by prior vaccination. Omicron infection induced a robust T-cell response in both unvaccinated and vaccinated, demonstrating that the evasive immune potential of primary Omicron infection affects humoral immunity more significantly than T-cell immunity.
| Original language | English |
|---|---|
| Journal | Microbiology Spectrum |
| Volume | 11 |
| Issue number | 6 |
| Number of pages | 17 |
| ISSN | 2165-0497 |
| DOIs | |
| Publication status | Published - 2023 |
Bibliographical note
Funding Information:
This work was supported by the special COVID-19 funding from the Faroese Research Council; The Carlsberg Foundation (CF20-0045); the Novo Nordisk Foundation (NNF20SA0063180, NFF205A0063505, and NNF20SA0064201); Svend Andersen Research Foundation (SARF2021); the cooperations: Nótaskip, Krúnborg og Borgartún. M.S.P. and P.G. conceptualized and designed the study. S.L. and J.L.H. eligible participants and sent the invitation. M.S.P. was responsible for data collection. E.H.E. prepared the questionnaires in RedCap, and S.K. entered data into REDCap. S.K., J.P.F., L.P-A., C.B.H., and R.B.O. carried out or were responsible for analyses. M.S.P., L.P-A., and C.B.H. carried out the statistical analysis. M.S.P. drafted the version of the manuscript. M.S.P., P.W., and P.G. received funding. All authors reviewed and approved the version.
Funding Information:
Thanks to all the participants and the technicians drawing the blood samples. Furthermore, thanks to Lina Hansen, research assistant, and the entire Department of Occupational Medicine and Public Health (now Department of Research) staff for assistance throughout the project. The authors would like to thank Mads Engelhardt Knudsen, Sif Kaas Nielsen, Bettina Eide Holm, and Victoria Marie Linderod Larsen from the Laboratory of Molecular Medicine at the Department of Clinical Immunology at Rigshospitalet for their excellent technical assistance. This work was supported by the special COVID-19 funding from the Faroese Research Council; The Carlsberg Foundation (CF20-0045); the Novo Nordisk Foundation (NNF20SA0063180, NFF205A0063505, and NNF20SA0064201); Svend Andersen Research Foundation (SARF2021); the cooperations∶ Nótaskip, Krúnborg og Borgartún. M.S.P. and P.G. conceptualized and designed the study. S.L. and J.L.H. identified eligible participants and sent the invitation. M.S.P. was responsible for data collection. E.H.E. prepared the questionnaires in RedCap, and S.K. entered data into REDCap. S.K., J.P.F., L.P-A., C.B.H., and R.B.O. carried out or were responsible for analyses. M.S.P., L.P-A., and C.B.H. carried out the statistical analysis. M.S.P. drafted the first version of the manuscript. M.S.P., P.W., and P.G. received funding. All authors reviewed and approved the final version.
Publisher Copyright:
Copyright © 2023 Petersen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
- cellular immune response, Faroe Islands, humoral immune response, Omicron
Research areas
ID: 396014324